RhumbLine Advisers’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $466K | Buy |
140,872
+36,509
| +35% | +$121K | ﹤0.01% | 2723 |
|
|
2025
Q1 | $303K | Sell |
104,363
-2,594
| -2% | -$7.52K | ﹤0.01% | 2885 |
|
|
2024
Q4 | $381K | Buy |
106,957
+3,259
| +3% | +$11.6K | ﹤0.01% | 2835 |
|
|
2024
Q3 | $516K | Buy |
103,698
+5,861
| +6% | +$29.2K | ﹤0.01% | 2676 |
|
|
2024
Q2 | $254K | Buy |
+97,837
| New | +$254K | ﹤0.01% | 3090 |
|
|
2021
Q2 | – | Sell |
-18,815
| Closed | -$98K | – | 2987 |
|
|
2021
Q1 | $98K | Sell |
18,815
-925
| -5% | -$4.82K | ﹤0.01% | 2935 |
|
|
2020
Q4 | $106K | Buy |
19,740
+2,960
| +18% | +$15.9K | ﹤0.01% | 2963 |
|
|
2020
Q3 | $81K | Sell |
16,780
-260
| -2% | -$1.26K | ﹤0.01% | 2905 |
|
|
2020
Q2 | $83K | Buy |
+17,040
| New | +$83K | ﹤0.01% | 2990 |
|